Position in NVS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$2,612,051
+$11,330 QoQ
Shares Held
16,667
-2.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.56%
of 13F equity value
Holder Rank
#379
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Patten Group, Inc. holds $22,707,053 across 8 Drug Manufacturers - General names. NVS ranks #5 (11.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
22,927 | $5,822,770 | |
| 2 | AZN |
Astrazeneca PLC
|
29,983 | $5,685,376 | |
| 3 | MRK |
Merck & Co., Inc.
|
26,376 | $3,389,316 | |
| 4 | LLY |
ELI LILLY & Co
|
2,822 | $3,384,791 | |
| 5 | NVS |
Novartis AG
This page
|
16,667 | $2,612,051 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
19,094 | $1,100,195 | |
| 7 | ABBV |
AbbVie Inc.
|
1,875 | $471,824 | |
| 8 | SNY |
Sanofi
|
5,643 | $240,730 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,612,051 | 16,667 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $2,600,721 | 17,026 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $2,362,264 | 17,134 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $2,156,099 | 16,813 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,039,381 | 16,853 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $1,891,815 | 16,970 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,590,142 | 16,341 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $1,884,832 | 16,387 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $1,757,973 | 16,513 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $1,558,320 | 16,110 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $1,626,626 | 16,110 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $1,610,508 | 15,811 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $1,593,570 | 15,792 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $1,452,864 | 15,792 | Shares | Sole | 2023-04-06 | |
| 2022-12-31 | $1,421,945 | 15,674 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,156,036 | 15,209 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $1,285,616 | 15,209 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $1,333,800 | 15,200 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $1,260,355 | 14,409 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $1,174,442 | 14,361 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,315,772 | 14,421 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $1,333,231 | 15,597 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $1,470,275 | 15,570 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $1,373,968 | 15,800 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $1,375,168 | 15,745 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $1,337,174 | 16,218 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||